# DESCRIPTION

## FIELD

- define field of disclosure

## BACKGROUND

- describe HDV biology

## SUMMARY

- summarize HDV detection in Sjögren's syndrome and lymphoma
- summarize methods of diagnosis and treatment

## DETAILED DESCRIPTION

### I. Abbreviations

- define abbreviations

### II. Terms and Methods

- define technical terms
- explain administration routes
- define agent and its types
- describe antibody structure and function
- explain monoclonal and humanized antibodies
- define antigen and its types
- describe antisense compounds and oligonucleotides
- define various terms related to diagnosis and disease
- define terms and methods
- describe hybridization and wash procedures
- define immunoassay and immunosuppressive agent
- describe inhibitor and its applications
- define isolated biological component
- describe lacrimal gland and lymphoma
- define non-steroidal anti-inflammatory drug
- describe oligonucleotide and operably linked sequences
- define patient and pharmaceutically acceptable vehicles
- describe preventing, treating or ameliorating a disease
- define primers and probes to promoting or restoring salivary production

### III. Introduction

- introduce Sjögren's syndrome
- motivate viral infection hypothesis

### IV. Overview of Several Embodiments

- introduce Sjögren's syndrome
- describe custom viral microarray design
- recover full-length genomes from patient samples
- test role of HDV in eliciting pSS-like phenotype
- diagnose Sjögren's syndrome by detecting HDV nucleic acid or antigen
- administer therapy to subject diagnosed with Sjögren's syndrome
- detect HDV nucleic acid or antigen in sample
- treat lymphoma by administering HDV inhibitor
- diagnose lymphoma by detecting HDV nucleic acid or antigen
- provide kits for detecting HDV nucleic acid

### V. Methods for Diagnosing Sjögren's Syndrome or Lymphoma

- diagnose Sjögren's syndrome by detecting HDV nucleic acid or antigen
- diagnose lymphoma susceptibility by detecting HDV nucleic acid or antigen
- detect HDV nucleic acid using methods like RT-PCR, northern blotting, or microarray
- detect HDV antigen using immunoassay methods like ELISA, Western blot, or radioimmunoassay
- confirm diagnosis using additional tests like ocular symptoms, oral symptoms, histopathology, or autoantibodies

### VI. Methods for the Treatment of Sjögren's Syndrome or Lymphoma

- describe treatment methods for Sjögren's syndrome
- describe treatment methods for lymphoma
- define HDV inhibitors
- motivate antisense compounds specific for HDV
- describe design and properties of antisense oligonucleotides
- describe design and properties of siRNA molecules
- describe modified oligonucleotides
- discuss base modifications or substitutions
- introduce farnesyltransferase inhibitors as HDV inhibitors
- outline administration of therapeutic agents
- provide examples of formulations for administration

## EXAMPLES

### Example 1

- detect HDV in Sjögren's syndrome salivary glands
- describe HDV detection method using viral microarray
- analyze HDV sequences in salivary gland tissue
- correlate HDV levels with clinical results
- induce pSS in mice using HDV antigens
- evaluate HDV antigen expression in mouse salivary glands
- analyze autoantibody profiles in HDV-treated mice
- discuss HDV as a viral trigger for Sjögren's syndrome

### Example 2

- detect HDV in lymphoma salivary gland tissue
- evaluate HDV antigen expression in mouse salivary glands and lymphoma development

### Example 3

- describe nested PCR assay

